|
BAZ2B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.095410E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.019400E-01 |
| Normal-vs-Stage2 |
3.372400E-02 |
| Normal-vs-Stage3 |
1.909960E-02 |
| Normal-vs-Stage4 |
2.360200E-02 |
| Stage1-vs-Stage2 |
1.135170E-01 |
| Stage1-vs-Stage3 |
4.336100E-02 |
| Stage1-vs-Stage4 |
6.226100E-02 |
| Stage2-vs-Stage3 |
8.149800E-01 |
| Stage2-vs-Stage4 |
9.091000E-01 |
| Stage3-vs-Stage4 |
9.058600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.172170E-01 |
| Normal-vs-AfricanAmerican |
8.060200E-01 |
| Normal-vs-Asian |
3.358800E-01 |
| Caucasian-vs-AfricanAmerican |
1.734200E-01 |
| Caucasian-vs-Asian |
6.990200E-01 |
| AfricanAmerican-vs-Asian |
3.383000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.926400E-02 |
| Normal-vs-Female |
1.736970E-01 |
| Male-vs-Female |
3.809400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.259200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.357900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.087540E-02 |
| Normal-vs-Age(81-100Yrs) |
2.310100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.034400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.415670E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.084500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.937600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.923700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.538200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.323400E-03 |
| Classical-VS-Follicular |
9.323700E-03 |
| Classical-VS-Other |
6.079600E-01 |
| Classical-VS-Normal |
5.016000E-01 |
| Tall-VS-Follicular |
5.475400E-01 |
| Tall-VS-Other |
4.242400E-01 |
| Tall-VS-Normal |
7.517000E-03 |
| Follicular-VS-Other |
7.416400E-01 |
| Follicular-VS-Normal |
2.570400E-02 |
| Other-VS-Normal |
4.222000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.499500E-02 |
| Normal-vs-N1 |
3.331200E-01 |
| N0-vs-N1 |
3.757800E-01 |
|
|
